From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.
This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.
Disparities in care are a complex issue requiring multiple strategies to solve, including approaches to improve the measurement of quality and reporting stratified performance estimates.
Identifying patients with osteoporosis or low bone mineral density and high risk for osteoporotic fractures is possible in administrative data using osteoporosis diagnoses and fracture risk profile.
Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.
The frailty determination of the Adjusted Clinical Groups“diagnoses based predictive model identified frail elders with moderate success compared with a validated screening questionnaire.
This study illustrates that where clinical trials are lacking, network meta-analysis can provide valuable insights into the potential clinical and economic benefits of value-based insurance design.
As value realization eludes integrated practice units (IPUs), the authors examine 6 key value drivers for IPU teams to competitively drive volumes and hone their multidisciplinary competencies.
Management of hepatitis C screening results can be optimized to ensure that patients receive high-quality care, reducing morbidity and costs related to the virus.
Big data could help identify potential clues about the immediate (and future) impact of coronavirus disease 2019, but it is in short supply.
This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.
An analysis of the opportunity cost associated with ambulatory medical care in the United States demonstrates substantial time costs for individuals and society.
In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.
Small primary care practices reap some organizational and quality of care improvements from electronic health records; however, challenges persist in achieving meaningful use standards.
This study found that brand price at launch and generic entry overstates long-run average pharmaceutical costs, with and without accounting for medical cost offsets.
This study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.
Health plans collect and use data on network providers' proficiency in languages other than English more commonly than race and ethnicity data on providers.
Midlevel providers were significantly less likely than physicians to change blood pressure (BP) treatment for complex diabetic patients presenting with elevated BP at a single visit.
Steps that need to be taken to address unmet needs and optimize outcomes for patients who have chronic kidney disease and type 2 diabetes.